Insider · CIK 0001966012
Guines LLC
Files at BTMD (biote Corp.). First filing Mar 17, 2025, latest May 8, 2025.
In brief
Guines LLC files SEC Form 4 as 10% owner at BTMD (biote Corp.). Since Mar 17, 2025, Guines LLC has reported 9 open-market buys worth $7.8M and 0 open-market sells worth $0, the latest filed on May 8, 2025.
A track record needs three past buys with six months of prices behind them; Guines LLC has 0, so none is measured yet.
The newest scored trade: bought $1.5M of BTMD on May 6, 2025, filed May 8, 2025, scored 58 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BTMD: biote Corp.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 58Moderate | BTMDbuy biote Corp. | $1.5M 447,714 shares | +11% | +10% from low-51% from high | |
| 25Weak | BTMDbuy biote Corp. | $6,371 1,933 shares | +0% | +8% from low-52% from high | |
| 20Weak | BTMDbuy biote Corp. | $29k 8,801 shares | +0% | +11% from low-51% from high | |
| 30Weak | BTMDbuy biote Corp. | $26k 7,874 shares | +0% | +8% from low-52% from high | |
| 41Moderate | BTMDbuy biote Corp. | $155k 48,439 shares | +1% | +6% from low-53% from high | |
| 43Moderate | BTMDbuy biote Corp. | $237k 74,440 shares | +2% | +9% from low-52% from high | |
| 71Notable | biote Corp. | $2.8M 856,609 shares | +28% | 0% from low-56% from high | |
| 60Notable | biote Corp. | $352k 106,000 shares | +3% | +8% from low-52% from high | |
| 71Notable | biote Corp. | $2.8M 856,609 shares | +28% | 0% from low-56% from high |
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 6, 2025 | BTMD biote Corp. | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See Footnote | +436,037 | $3.26 | $1.4M | 4,611,071 | May 8, 2025 |
| May 7, 2025 | BTMD biote Corp. | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See Footnote | +11,677 | $3.35 | $39k | 4,622,748 | May 8, 2025 |
| Apr 30, 2025 | BTMD biote Corp. | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +1,933 | $3.30 | $6,371 | 4,175,034 | May 2, 2025 |
| Apr 21, 2025 | BTMD biote Corp. | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +8,801 | $3.27 | $29k | 4,173,101 | Apr 23, 2025 |
| Apr 16, 2025 | BTMD biote Corp. | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: Footnote | +1,000 | $3.29 | $3,292 | 4,157,426 | Apr 18, 2025 |
| Apr 17, 2025 | BTMD biote Corp. | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: Footnote | +6,874 | $3.29 | $23k | 4,164,300 | Apr 18, 2025 |
| Apr 8, 2025 | BTMD biote Corp. | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +34,907 | $3.21 | $112k | 4,142,894 | Apr 10, 2025 |
| Apr 9, 2025 | BTMD biote Corp. | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +13,532 | $3.21 | $43k | 4,156,426 | Apr 10, 2025 |
| Apr 3, 2025 | BTMD biote Corp. | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +7,321 | $3.24 | $24k | 4,040,868 | Apr 7, 2025 |
| Apr 4, 2025 | BTMD biote Corp. | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +23,741 | $3.24 | $77k | 4,064,609 | Apr 7, 2025 |
| Apr 7, 2025 | BTMD biote Corp. | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +43,378 | $3.15 | $137k | 4,107,987 | Apr 7, 2025 |
| Mar 13, 2025 | BTMD biote Corp. | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +750,000 | $3.22 | $2.4M | 3,820,938 | Apr 3, 2025 |
| Mar 14, 2025 | BTMD biote Corp. | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +106,509 | $3.50 | $372k | 3,927,447 | Apr 3, 2025 |
| Mar 17, 2025 | BTMD biote Corp. | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +100 | $3.74 | $374 | 3,927,547 | Apr 3, 2025 |
| Mar 31, 2025 | BTMD biote Corp. | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +106,000 | $3.32 | $352k | 4,033,547 | Apr 2, 2025 |
| Mar 13, 2025 | BTMD biote Corp. | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +750,000 | $3.22 | $2.4M | 3,820,938 | Mar 17, 2025 |
| Mar 14, 2025 | BTMD biote Corp. | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +106,509 | $3.50 | $372k | 3,927,447 | Mar 17, 2025 |
| Mar 17, 2025 | BTMD biote Corp. | POpen-market purchase Class A common stock, par value $0.0001 per shareindirect: See footnote | +100 | $3.74 | $374 | 3,927,547 | Mar 17, 2025 |
Questions about Guines LLC
Answered from the filings on this page, as of the latest one.
Is Guines LLC buying or selling?
Not in the last 12 months. Guines LLC's latest open-market trade on SEC Form 4 was bought $1.5M of BTMD on May 6, 2025.
How did Guines LLC's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Guines LLC has 0.
Where does Guines LLC file Form 4?
Guines LLC has filed Form 4 at BTMD (biote Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.